课题基金 / 基金详情

Intravenous Ketamine versus Personalized Accelerated Brain Stimulation in Treatment-Resistant Depression: A Pilot Randomized Feasibility Trial of Rapid-Acting Treatments (IKARE-TRD)

Intravenous Ketamine versus Personalized Accelerated Brain Stimulation in Treatment-Resistant Depression: A Pilot Randomized Feasibility Trial of Rapid-Acting Treatments (IKARE-TRD)
静脉注射氯胺酮与个性化加速脑刺激治疗难治性抑郁症：快速起效治疗的随机试点可行性试验 (IKARE-TRD)
批准号：
490031
负责人：
Bhat Venkat
金额：
$44.31万
依托单位：
Unity Health Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=490031&lang=en
关键词：
Brain Stimulation Iv Ketamine Pilot Trial Randomized Controlled Trial Treatment-Resistant Depression

项目摘要

项目成果

Bhat Venkat的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clinical depression affects more than 6 million Canadians. More than a third of them do not respond positively to antidepressant medications, meeting the criteria for treatment-resistant depression (TRD). Research shows that ketamine, a drug that blocks g
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Electrical Stimulation for Major Depressive Disorder: A Pilot Randomized Controlled Trial
  • 批准号：
    462579
  • 项目类别：
    Operating Grants
  • 资助金额：
    $27.59万
  • 财政年份：
    2022
  • 负责人：
    Bhat Venkat
  • 依托单位：
    Unity Health Toronto
Developing a Rational Approach Towards Offering Procedural Interventions (ECT & rTMS) for At Risk Populations in Psychiatry During the COVID-19 Pandemic: An Interdisciplinary Evidence Synthesis.
  • 批准号：
    425075
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2020
  • 负责人：
    Bhat Venkat
  • 依托单位：
    Unity Health Toronto
Maternal and perinatal complications, therapeutic response and side effects of Methylphenidate: an intra-familial study in children with Attention Deficit Hyperactivity Disorder
海外基金